Sun Pharma to acquire U.S. firm Organon in $11.75 billion deal
Sun Pharmaceutical Industries Ltd has announced that it has entered into a definitive agreement under which it will acquire all outstanding shares of Organon for $14.00 per share in an…
Pharma exports rose 2% to over $31 billion in FY26 despite sharp decline in March
India’s pharmaceutical exports rose more than 2% year on year to $31.11 billion in FY26 despite a 23% decline in March amid the fallout of the West Asia war. A…
Indian National Sentenced In Counterfeit Cancer Drug Trafficking Case
Washington DC : Indian national Sanjay Kumar, 45, was sentenced today to 43 months in prison and one year of supervised release for conspiring to sell tens of thousands of…
Chhattisgarh eyes investments with high-incentive policy and dedicated pharma park
The state has garnered investment commitments worth Rs 7.83 lakh crore across sectors including pharma, healthcare and allied sectors Chhattisgarh is stepping up efforts to position itself as a leading…
Pharma company, its employees convicted for ‘illegal diversion” of meth precursor abroad
Rajkot: The Narcotics Control Bureau (NCB) on Monday said it has secured a “major conviction” in the case of illegal diversion of medical drugs involving a Haryana-based company via Gujarat’s Pipavav…
Ayurveda practitioner fined by ISM Council for violation of professional ethics
Thiruvanantpuram: The Ethics Committee of the Council of Indian Systems of Medicine, Kerala State Medical Councils, has imposed a fine of ₹50,000 on a registered Ayurveda practitioner for advertising his…
Centre plans separate licence regime for bulk drugs, APIs: Report
India is preparing to revamp its pharmaceutical licensing system amid growing scrutiny over drug safety lapses. Mint has learnt that the government is working on a separate wholesale licensing framework…
US, UK ink tariff-free deal to boost pharma trade
THE UNITED STATES announced a deal with Britain for zero tariffs on pharmaceutical products and medical technology on Monday which will lead to Britain spending more on medicines. The deal…















